Lawrence J. Hineline Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week ago
Lawrence J. Hineline has an estimated net worth of at least $26.0 million*, as of Dec. 18, 2024. They own 0 shares of ITCI stock. They have sold 500,438 shares of ITCI stock since 2021, for an estimated $26.0 million.
Lawrence J. Hineline $ITCI SEC Form 4 Insider Trading
Lawrence J. Hineline has filed a total of 44 insider trades in $ITCI since 2021. Their most recent trade was a sale of 6,514 shares, made on Mar 07, 2024. Their largest trade was a sale of 100,803 shares, made on Dec 21, 2021. We estimate that they now own 0 shares of $ITCI, worth an estimated $0.
Insider Trading at $ITCI
There have been a total of 247 insider trades reported at $ITCI since 2021, with 0 shares purchased and 3.0 million shares sold. The most active insider traders in $ITCI stock have been Sharon Mates, Mark Neumann, and Michael Halstead. The most recent trade was a sale of 27,667 shares reported by Sharon Mates (Chairman and CEO), made on Dec 04, 2024.
History of Insider Stock Trades by Lawrence J. Hineline
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
ITCI | Sale | 6,514 | Mar 07, 2024 | March 11, 2024, 8:33 p.m. |
ITCI | Sale | 64 | Mar 11, 2024 | March 11, 2024, 8:33 p.m. |
ITCI | Sale | 4,475 | Mar 11, 2024 | March 11, 2024, 8:33 p.m. |
ITCI | Sale | 29 | Mar 11, 2024 | March 11, 2024, 8:33 p.m. |
ITCI | Sale | 1,100 | Mar 11, 2024 | March 11, 2024, 8:33 p.m. |
ITCI | Sale | 4,453 | Mar 11, 2024 | March 11, 2024, 8:33 p.m. |
ITCI | Sale | 6,618 | Mar 07, 2024 | March 11, 2024, 8:33 p.m. |
ITCI | Sale | 6,867 | Feb 26, 2024 | Feb. 27, 2024, 9 p.m. |
ITCI | Sale | 600 | Feb 26, 2024 | Feb. 27, 2024, 9 p.m. |
ITCI | Sale | 5,282 | Feb 26, 2024 | Feb. 27, 2024, 9 p.m. |
ITCI | Sale | 288 | Feb 26, 2024 | Feb. 27, 2024, 9 p.m. |
ITCI | Sale | 300 | Feb 26, 2024 | Feb. 27, 2024, 9 p.m. |
ITCI | Sale | 185 | Feb 02, 2024 | Feb. 5, 2024, 7:05 p.m. |
ITCI | Sale | 10,998 | Feb 02, 2024 | Feb. 5, 2024, 7:05 p.m. |
ITCI | Sale | 44,035 | Jun 14, 2023 | June 16, 2023, 5:05 p.m. |
ITCI | Sale | 3,592 | Jun 14, 2023 | June 16, 2023, 5:05 p.m. |
ITCI | Sale | 34,227 | Jun 14, 2023 | June 16, 2023, 5:05 p.m. |
ITCI | Sale | 2,700 | Mar 10, 2023 | March 13, 2023, 7:32 p.m. |
ITCI | Sale | 258 | Mar 13, 2023 | March 13, 2023, 7:32 p.m. |
ITCI | Sale | 5,324 | Mar 13, 2023 | March 13, 2023, 7:32 p.m. |
ITCI | Sale | 12,963 | Mar 10, 2023 | March 13, 2023, 7:32 p.m. |
ITCI | Sale | 7,455 | Feb 24, 2023 | Feb. 27, 2023, 9 p.m. |
ITCI | Sale | 52,279 | Feb 17, 2023 | Feb. 22, 2023, 9:02 p.m. |
ITCI | Sale | 94 | Feb 21, 2023 | Feb. 22, 2023, 9:02 p.m. |
ITCI | Sale | 900 | Feb 21, 2023 | Feb. 22, 2023, 9:02 p.m. |
ITCI | Sale | 800 | Feb 21, 2023 | Feb. 22, 2023, 9:02 p.m. |
ITCI | Sale | 8,649 | Feb 21, 2023 | Feb. 22, 2023, 9:02 p.m. |
ITCI | Sale | 1,689 | Feb 17, 2023 | Feb. 22, 2023, 9:02 p.m. |
ITCI | Sale | 33,303 | Sep 21, 2022 | Sept. 23, 2022, 9:01 p.m. |
ITCI | Sale | 31,861 | Sep 21, 2022 | Sept. 23, 2022, 9:01 p.m. |
ITCI | Sale | 3,983 | Feb 24, 2022 | Feb. 25, 2022, 8:04 p.m. |
ITCI | Sale | 100 | Feb 24, 2022 | Feb. 25, 2022, 8:04 p.m. |
ITCI | Sale | 3,371 | Feb 24, 2022 | Feb. 25, 2022, 8:04 p.m. |
ITCI | Sale | 4,627 | Feb 22, 2022 | Feb. 23, 2022, 8:02 p.m. |
ITCI | Sale | 5,816 | Feb 22, 2022 | Feb. 23, 2022, 8:02 p.m. |
ITCI | Sale | 12,434 | Jan 10, 2022 | Jan. 11, 2022, 9:02 p.m. |
ITCI | Sale | 4,100 | Jan 10, 2022 | Jan. 11, 2022, 9:02 p.m. |
ITCI | Sale | 3,105 | Jan 10, 2022 | Jan. 11, 2022, 9:02 p.m. |
ITCI | Sale | 100,803 | Dec 21, 2021 | Dec. 23, 2021, 8 p.m. |
ITCI | Sale | 600 | Dec 21, 2021 | Dec. 23, 2021, 8 p.m. |
ITCI | Sale | 3,800 | Dec 21, 2021 | Dec. 23, 2021, 8 p.m. |
ITCI | Sale | 9,200 | Dec 21, 2021 | Dec. 23, 2021, 8 p.m. |
ITCI | Sale | 35,135 | Dec 21, 2021 | Dec. 23, 2021, 8 p.m. |
ITCI | Sale | 25,462 | Dec 21, 2021 | Dec. 23, 2021, 8 p.m. |
$ITCI Executives and Stock Owners with Insider Trades
-
Sharon Mates, Chairman, President & CEO
-
Mark Neumann, EVP, Chief Commercial Officer
-
Michael Halstead, EVP and General Counsel
-
Lawrence J. Hineline, SVP of Finance CFO
-
Sharon Mates, Chairman and CEO
-
Suresh K. Durgam, EVP, Chief Medical Officer
-
Lawrence J. Hineline, SVP of Finance, CFO
-
Suresh K. Durgam, Chief Medical Officer
-
Michael Halstead, President
-
Suresh K. Durgam, SVP, Chief Medical Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.